Skip to main content
. 2023 Jul 5;15:1210191. doi: 10.3389/fnagi.2023.1210191

TABLE 2.

Summary of the expression change, molecular target, and significance of miRNAs differentially expressed in the CSF of AD patients.

Name Change Target Effect on translation and significance
miR-100-5p Wallach et al., 2021 TLR7/8
mTOR
Increased binding and activation of microglial TLR7/8 promotes autonomous neurodegeneration and cortical accumulation of microglia; Increased inhibition of PI3K/Akt/mTOR pathway in late-stage AD leads to increased neuronal apoptosis Ye et al., 2015; Wallach et al., 2021
miR-101-3p Sørensen et al., 2016; Zhou et al., 2019 APP Although upregulated in CSF, decreased brain levels cause loss of APP inhibition increasing Aβ deposition Vilardo et al., 2010; Zhou et al., 2019; Lee et al., 2021
miR-103 Denk et al., 2015 BACE1 Decreased inhibition of BACE1 increases Aβ deposition and ROS production promoting neuronal loss Denk et al., 2015; Lee et al., 2021
miR-106a Denk et al., 2015 APP Although upregulated in CSF, decreased brain levels cause loss of APP inhibition increasing Aβ deposition Lee et al., 2021
miR-10b-5p Sørensen et al., 2016 HODX10 Increased inhibition of HODX10 and subsequent activation of the Rho/ROCK signaling pathway mediates hippocampal neuronal injury and inflammation Ruan et al., 2021
miR-124-3p Burgos et al., 2014 CAV1 Decreased inhibition of Caveolin-1 and subsequent modulation of the PI3K/Akt/GSK-3b pathway promotes tau hyperphosphorylation, neurofibrillary tangle formation, and cellular apoptosis Kang et al., 2017; Samadian et al., 2021
miR-125b Galimberti et al., 2014 ERK1/2
Bcl-W
DUSP6
PPP1CA
Increased activation of ERK1/2 and downregulation of tau phosphatases (Bcl-W, DUSP6, PPP1CA) promotes tau hyperphosphorylation and reduces neuronal cell viability Banzhaf-Strathmann et al., 2014
miR-125b-5p Sørensen et al., 2016; Liu et al., 2022 BACE1 Decreased inhibition of BACE1 increases Aβ deposition and ROS production promoting neuronal loss Li et al., 2020
miR-1273g-3p Kim et al., 2021 BACE1
Nicastrin
TIMM13
GLRX5
MTCH1
Increased activation of the JNK pathway upregulates BACE1 and Nicastrin expression inducing Aβ and ROS production; Increased inhibition of mitochondrial genes (TIMM13, GLRX5, MTCH1) results in mitochondrial dysfunction and BACE1 upregulation Kim et al., 2021
miR-130a-3p Sørensen et al., 2016 DAPK1 Decreased inhibition of DAPK1 promotes hippocampal neurotoxicity and is associated with worse cognitive decline Wang et al., 2021
miR-132 Denk et al., 2015 GTDC-1
CDK5
SIRT1
Increased inhibition of GTDC-1 promotes tau hyperphosphorylation and neuronal apoptosis by upregulation of Bax and downregulation of BCL2; Increased stimulation of CDK5 promotes tau hyperphosphorylation; Increased SIRT1 inhibition promotes tau hyperphosphorylation and amyloidogenesis Hernandez-Rapp et al., 2016; Liu and Zhang, 2019
miR-140-5p Lusardi et al., 2017 ADAM10
SOX2
Although downregulated in CSF, increased brain levels inhibit expression of SOX2 and ADAM10 promoting the intraneural accumulation of Aβ and progression of AD Akhter et al., 2018
miR-142-3p Lusardi et al., 2017 MAPT Decreased regulation of MAPT compromises oligodendrocyte differentiation and cortical myelination exacerbating neurodegeneration Hinman et al., 2021
miR-143-3p Sørensen et al., 2016 NRG1 Increased inhibition of BACE1-dependent cleavage of NRG1 reduces neuronal cell viability and is associated with worse cognitive decline Sun et al., 2020
miR-146a Kiko et al., 2014; Liu et al., 2022 Nkd2 Overexpression of miRNA-146a in vivo has been demonstrated to induce microglial polarization (M1 pro-inflammatory to M2 phagocytic) and inhibit NLRP3 inflammasome formation enhancing Aβ clearance and reducing neuroinflammation, respectively, but the exact mechanisms remain unknown Liang et al., 2021
miR-146a-5p Sørensen et al., 2016 TIGAR Increased inhibition of TIGAR decreases NADPH production and GSH formation facilitating ROS production and neuronal pyroptosis (caspase-1-dependent cell death) Lei et al., 2021
miR-150-5p Sørensen et al., 2016 PDCD4 Associated with lower global cognitive scores, higher CSF t-tau, lower CSF Aβ42 levels, and lower blood PDCD4 Chia et al., 2022
miR-15a-5p Liu et al., 2022 ERK1 Decreased inhibition of ERK1 promotes tau phosphorylation and AD progression Hébert et al., 2010
miR-15b Denk et al., 2015 BACE1 Although upregulated in CSF, decreased brain levels cause loss of BACE1 inhibition increasing Aβ deposition Gong et al., 2017; Liu et al., 2022
miR-16 Denk et al., 2015 BACE1 Decreased inhibition of BACE1 increases Aβ deposition at the early stages of AD Zhong et al., 2018; Manna et al., 2020
miR-16-5p Lusardi et al., 2017 BACE1 Decreased inhibition of BACE1 increases Aβ deposition and ROS production promoting neuronal loss Zhang et al., 2020
miR-193a-3p Lusardi et al., 2017 PTEN Decreased inhibition of PTEN facilitates the dysregulation of the PI3K/AKT cell survival signaling pathway leading to neuronal apoptosis and AD progression Takalkar et al., 2016
miR-195 Cao et al., 2021; Liu et al., 2022 SYNJ1
MFN2
Decreased inhibition of SYNJ1 facilitates the cleavage of neuronal membrane filaments and is positively correlated with the patient’s MMSE score while negatively correlated with CSF tau levels; Co-downregulation of MFN2 proteins facilitates mitochondrial dysfunction by fusion-fission imbalance Zhang R. et al., 2016; Cao et al., 2021
miR-19b-3p Sørensen et al., 2016 BACE1
STAT3
Decreased inhibition of BACE1 leads to increased Aβ deposition; Loss of downregulation of STAT3 phosphorylation and activation leads to reactive gliosis and poor cognitive function Wu et al., 2017; Zhang et al., 2020
miR-204-5p Sørensen et al., 2016 TRPML1 Increased inhibition of TRPML1 disrupts lysosomal storage/transport and is associated with dysregulation of autophagy, increased accumulation of intraneural Aβ, decreased mitophagy, and decreased ROS removal Zhang L. et al., 2021
miR-206 Sørensen et al., 2016 BDNF
IGF1
Increased inhibition of BDNF results in synaptic dysfunction and impaired memory consolidation; Increased inhibition of IGF1 compromises microglial-mediated Aβ clearance and promotes LPS-induced neuroinflammation Lee et al., 2012; Xing et al., 2016
miR-210 Liu et al., 2022 VEGF Decreased stimulation of VEGF is associated with AD progression Zhu et al., 2015
miR-22-3p Sørensen et al., 2016 SOX9
MAPK14
Decreased inhibition of SOX9 and MAPK14 indirectly promotes Aβ deposition and neuronal apoptosis Ji Q. et al., 2019; Xia et al., 2022
miR-221-3p Sørensen et al., 2016 ADAM10 Increased inhibition of ADAM10 promotes intraneural accumulation of Aβ Manzine et al., 2018
miR-223-3p Lusardi et al., 2017 NLRP3 Decreased inhibition of the NLRP3 protein leads to inflammasome formation and sustained neuroinflammation in AD and is positively correlated to the MMSE score Bauernfeind et al., 2012; Jia and Liu, 2016
miR-23b-3p Sørensen et al., 2016 Gnt-III
GSK-3β
Decreased inhibition of GnT-III facilitates APP cleavage by BACE1 promoting Aβ production; Decreased inhibition of GSK-3b facilitates tau hyperphosphorylation and ROS production Pan et al., 2021; Jiang et al., 2022
miR-26b Galimberti et al., 2014 Rb1/E2F
NEP
Although downregulated in CSF, increased brain levels upregulate the expression of Rb1/E2F promoting neuronal apoptosis; increased downregulation of NEP increases Aβ aggregation and impairs memory Absalon et al., 2013; Chu et al., 2018
miR-27a-3p Sala Frigerio et al., 2013 NEAT1 Decreased inhibition of NEAT1 increases BACE1 activity and Aβ deposition which promotes the progression of AD but no correlation with MMSE/MOCA score exists yet He et al., 2022
miR-27b-3p Lusardi et al., 2017 CCL2/CCR2 Impairment of the chemokine/chemokine receptor axis in blood-derived monocytes (BDMs) results in decreased clearance of Aβ aggregates Wang et al., 2019
miR-29a Kiko et al., 2014; Müller et al., 2016 BACE1 Although upregulated in CSF, decreased brain levels cause loss of BACE1 inhibition increasing Aβ deposition and ROS production promoting neuronal loss Hébert et al., 2008
miR-29a-3p Lusardi et al., 2017 NAV3
ZNF346
LIF
Increased activation of NAV3, ZNF346, and LIF affects neuron regeneration, survival, and differentiation, respectively Peña-Bautista et al., 2022
miR-29b Kiko et al., 2014 BACE1 Although upregulated in CSF, decreased brain levels cause loss of BACE1 inhibition increasing Aβ deposition and ROS production promoting neuronal loss Hébert et al., 2008
miR-29b-3p Sørensen et al., 2016 BCL2L2
MCL-1
Increased inhibition of anti-apoptotic factors BCL2L2 and MCL-1 promotes neuronal cell death Lungu et al., 2013; Satoh et al., 2015
miR-29c Denk et al., 2015 BACE1 Decreased inhibition of BACE1 increases Aβ deposition and ROS production promoting neuronal loss Lei et al., 2015; Manna et al., 2020
miR-29c-3p Sørensen et al., 2016 BACE1
STAT3
Decreased inhibition of BACE1 leads to increased Aβ deposition; Loss of downregulation of STAT3 phosphorylation and activation leads to reactive gliosis and poor cognitive function Wu et al., 2017
miR-30a-5p Sørensen et al., 2016 ADAM10
SIRT1
BDNF
Increased SIRT1 inhibition promotes tau hyperphosphorylation and accelerates neuronal damage; Increased inhibition of ADAM10 promotes intraneural accumulation of Aβ; Increased inhibition of BDNF results in synaptic dysfunction and impaired memory consolidation Croce et al., 2013; Sun et al., 2022
miR-328-3p Tan et al., 2021; Liu et al., 2022 BACE1 Decreased inhibition of BACE1 increases Aβ deposition and ROS production promoting neuronal loss Thangavelu et al., 2020; Lee et al., 2021
miR-331-3p Lusardi et al., 2017 SQSTM1
OPTN
Although downregulated in early stage AD, this miRNA increases later on promoting Aβ plaque formation and impairing its autophagic clearance Chen et al., 2021
miR-335-5p Sørensen et al., 2016 JNK3 Decreased inhibition of the JNK3 signaling pathway results in increased Aβ deposition Denk et al., 2015; Wang et al., 2020
miR-340-5p Lusardi et al., 2017 BACE1 Decreased inhibition of BACE1 increases Aβ deposition and ROS production promoting neuronal loss Liu et al., 2022
miR-34a Denk et al., 2015; Liu et al., 2022 NDUFC2
SHDC
COX10
SIRT1
PTPA
NR2A
VAMP2
SYT1
ADAM10
Increased inhibition of electron transport chain complexes (NDUFC2, SHDC, COX10) compromises mitochondrial function and ATP formation leading to neuronal cell death; Increased SIRT1 and PTPA inhibition promotes tau hyperphosphorylation; Increased NR2A inhibition on post-synaptic membranes compromises synaptic plasticity impairing working memory; Increased VAMP2 and SYT1 inhibition on pre-synaptic membranes compromises vesicle exo/endocytosis; Increased inhibition of ADAM10 promotes intraneural accumulation of Aβ and rapid cognitive decline Sarkar et al., 2016, 2019; Liu et al., 2022
miR-361-5p Sørensen et al., 2016 BACE1 Decreased inhibition of BACE1 increases Aβ deposition and ROS production promoting neuronal loss Ji Y. et al., 2019
miR-373-5p Sørensen et al., 2016 NLRP3 Decreased inhibition of the NLRP3 protein leads to inflammasome formation and sustained neuroinflammation in AD Taşdelen et al., 2022
miR-374b-5p Sørensen et al., 2016 BACE1 Although upregulated in CSF, decreased brain levels cause loss of BACE1 inhibition increasing Aβ deposition Liu et al., 2022
miR-384 Liu et al., 2022 APP
BACE1
Decreased regulation of APP increases Aβ production; Loss of downregulation of BACE1 leads to increased Aβ deposition Liu et al., 2014
miR-423-5p Sørensen et al., 2016 COX6A2 Increased inhibition of COX6A2 dramatically decreases ATP production levels compromising cell survival and energy metabolism Siengdee et al., 2015
miR-433 Burgos et al., 2014 JAK2/STAT3 Decreased inhibition of the JAK2/STAT3 pathway allows for increased neuronal proliferation and apoptosis, reactive gliosis, synaptic dysfunction, and Aβ aggregation Wang and Zhang, 2020; Liu et al., 2022
miR-497-5p Sørensen et al., 2016 Endophilin-1 Decreased inhibition of Endophilin-1 allows for the sustained downregulation of tight junction proteins (ZO-1, occludin, claudin-5) increasing BBB permeability and contributing to AD neuroinflammation Zhu et al., 2019
miR-613 Liu et al., 2022 BDNF Increased inhibition of BDNF results in synaptic dysfunction and is associated with decreased hippocampal neuron survival and proliferation Li et al., 2016
miR-9-3p Sørensen et al., 2016 Dmd
SAP97
REST
Modulates dendritic growth and synaptic plasticity of hippocampal neurons by targeting long-term potentiation genes (Dmd, SAP97) and the REST protein; Although initially upregulated, CSF miRNA-9-3p levels are reported to decrease with AD progression Giusti et al., 2014; Sim et al., 2016
miR-9-5p Burgos et al., 2014 GSK-3β
NRF2/KEAP1
Decreased inhibition of GSK-3b facilitates ROS production, mitochondrial dysfunction, and neuronal apoptosis; Decreased activation of NRF2/KEAP1 signaling pathways results in downregulation of antioxidant enzymes (HO-1, SOD-1, GCLC) Yang et al., 2017; Liu et al., 2020
miR-92a-3p Sørensen et al., 2016 AMPARs Decreased translation and incorporation of GluA1-containing AMPA receptors into the synaptic membranes of hippocampal neurons is associated with defective synaptic transmission and plasticity Letellier et al., 2014
miR-let-7i-5p Sørensen et al., 2016 TLR4 Increased activation of extracellular TLR4 contributes to widespread neuronal damage Sørensen et al., 2016